PEBP1, PTGDS, SOD3, CHGA, and SCG5 have been repeatedly identified (4 out of 10 studies) when monitoring for changes in CSF in AD relative to controls (Figure 4b). This evidence concerns the gene PEBP1 and Alzheimer disease.